Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors

Rhea-AI Summary

Glucose Health (OTC: GLUC) appointed Edmund “Ned” Burke to its Board of Directors effective Oct 27, 2025. Burke is a veteran financial executive with 40+ years at firms including Pioneer Funds and Fidelity, and served as CEO of ALPS Holdings until his June 2019 retirement.

Key highlights: Burke led ALPS revenue growth from $15 million to $225 million (2005–2019; ~19.79% CAGR), negotiated ALPS sales to Lovell Minnick Partners (2005) and DST Systems (2011), and received the 2016 NOVA Award. He also serves on multiple mutual fund boards and is noted as one of Glucose Health’s largest shareholders.

Positive

• ALPS revenue growth from $15M to $225M (2005–2019)
• 19.79% CAGR reported for ALPS revenue over ~15 years
• Board alignment as one of Glucose Health’s largest shareholders

Negative

• Retired from CEO role in June 2019 (no recent CEO operational role)

News Market Reaction

+0.20%

1 alert

+0.20% News Effect

On the day this news was published, GLUC gained 0.20%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BENTONVILLE, Ark., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) is pleased to announce the appointment of Edmund (Ned) Burke, a highly accomplished financial services executive, to its Board of Directors. With more than four decades of experience at prominent investment firms, including Pioneer Funds and Fidelity Investments, Mr. Burke brings exceptional financial acumen and strategic insight to the company’s leadership team.

Mr. Burke most recently served as Chief Executive Officer of ALPS Holdings, Inc., where he played a pivotal role in the successful distribution and administration of closed-end funds, open-end funds, and exchange-traded funds (ETFs). Under his direction, ALPS expanded its services to include critical back-office solutions for many of the nation’s top money management firms. During his tenure, Mr. Burke established and managed key relationships with notable organizations, including Select Sector SPDR Exchange Traded Funds, GE Investment Management, and Clough closed-end funds.

His outstanding contributions to the financial services industry were recognized in 2016 when he received the NOVA Award from the National Investment Company Service Association, honoring his leadership and innovation in the securities sector.

As CEO, Mr. Burke oversaw impressive growth at ALPS, expanding the firm’s revenue from $15 million to $225 million from 2005 to 2019, representing a compound annual growth rate of 19.79% over approximately 15 years. In 2005, he and his team successfully negotiated the sale of ALPS to Lovell Minnick Partners, a private equity firm specializing in financial services investments. Later, in 2011, DST Systems, Inc. acquired ALPS after Mr. Burke and his team had firmly established it as a leading player in the financial services industry. Mr. Burke retired from ALPS in June 2019

Mr. Burke’s extensive experience in building and scaling financial organizations will be invaluable as Glucose Health, Inc., continues to expand operations and enhance shareholder value. In addition to his new Board role at Glucose Health, Mr. Burke serves on the mutual fund boards of several prominent money management firms, including Financial Investors Trust, ALPS ETF Trust, Clough Funds, and Liberty All-Star Trust.

Commenting on the appointment, Mark Schaftlein, CEO of Glucose Health, stated:

“Ned is an outstanding addition to our Board of Directors. His business experience and proven success in building high-performing organizations will be instrumental as we continue to advance Glucose Health’s growth strategy. As one of our largest shareholders, Ned’s interests are perfectly aligned with those of our broader shareholder base, and I look forward to working closely with him to achieve our long-term objectives.”

Mr. Burke earned a Bachelor of Arts degree in Economics from the University of New Hampshire.

Contact:
Investor Relations
info@glucosehealthinc.com
www.glucodown.com
www.fiberup.com
OTC: GLUC

FAQ

Who is Edmund “Ned” Burke and why did Glucose Health (GLUC) appoint him on Oct 27, 2025?

Edmund Burke is a 40+ year financial services executive, former CEO of ALPS Holdings, appointed for his strategic and financial experience.

What growth track record does Ned Burke bring to Glucose Health (GLUC)?

As ALPS CEO he grew revenue from $15M to $225M between 2005 and 2019, a reported 19.79% CAGR.

Does Ned Burke have transaction experience relevant to GLUC shareholders?

Yes; he negotiated ALPS sales to Lovell Minnick Partners (2005) and to DST Systems (2011).

Is Ned Burke actively serving in other industry roles while joining GLUC’s board?

Yes; he serves on several mutual fund boards including Financial Investors Trust and ALPS ETF Trust.

Will Ned Burke’s appointment affect shareholder alignment for GLUC (OTC: GLUC)?

Management notes Burke is one of the company’s largest shareholders, signaling aligned interests with existing shareholders.